Allostery Investments’s Akero Therapeutics AKRO Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Shares
Change %
Capital Flow Portfolio Weight Portfolio Position
2025
Q2
$1.2M Buy
22,500
+4,500
+25% +$240K 15.29% 2
2025
Q1
$729K Buy
+18,000
New +$729K 1.05% 23